Dr. Christopher S. Calder, MD

Dr. Calder practices at Presbyterian Medical Group in Albuquerque, New Mexico.

Dr. Calder's NPI, 1386693596, was assigned on May 8, 2006. Dr. Calder holds New Mexico license MD2012-0761.

Dr. Calder's primary practice is Presbyterian Medical Group, at 6100 Pan American NE Fwy, Albuquerque, NM 87109 in Bernalillo County. The practice phone is (505) 823-8556.

Dr. Calder's primary practice is Presbyterian Medical Group in Albuquerque, New Mexico. Dr. Calder is also affiliated with Presbyterian Hospital. The medical group on file is Presbyterian Medical Group. Dmand AI also links Dr. Calder to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Calder practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Calder's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Calder's licenses on file in 2 states: New Mexico and New York.

CMS data shows 319 Medicare services from Dr. Calder across 11 procedure codes in 2024, for 113 Medicare patients. Medicare paid $17,752 for them. Every service was in an office.

CMS counts 113 Medicare patients who saw Dr. Calder in 2024. The largest group is 75 to 84, with 48 patients. 73% of them have high cholesterol, and 65% have arthritis. 14% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Calder's median patient age at 64, with 62% women.

In 2024, Dr. Calder wrote 318 Medicare Part D claims for 79 patients. 93% of them were for generic drugs. CMS names the drug for 165 of them, across 9 drugs with 11 or more claims each, at $4,173 in total drug cost. In 2023, CMS named 293 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Calder for performance year 2024, reported as part of a group. Dr. Calder accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Calder, published from 2017 to 2020. Dr. Calder has published most often in J Stroke Cerebrovasc Dis. Dr. Calder's most frequent co-authors are Asad Ikram, MD, Atif Zafar, MD and Corey Ford, MD.

Dmand AI links Dr. Calder to 1 clinical trial. Conditions studied include Miller Fisher Syndrome and Guillain-Barre Syndrome.

CMS Open Payments shows 140 general payments to Dr. Calder from 36 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Novartis Pharmaceuticals Corporation paid the most, $345.